The Enzen Trial: Comparison of Evar Endoprosthesis: Endurant Versus Zenith

NCT05969782 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2023-08-01

No results posted yet for this study

Summary

A prospective, non-randomized trial of patients submitted to EVAR for aortoiliac aneursym using Endurant II (Medtronic) or Zenith (Cook).

Conditions

  • Aortic Aneurysm
  • Aortoiliac Atherosclerosis

Interventions

DEVICE

EVAR

Endovascular repair of aortoiliac aneurysm using Zenith or Endurant

Sponsors & Collaborators

  • Hospital do Servidor Publico Estadual

    lead OTHER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-01
Primary Completion
2024-07-01
Completion
2024-09-01
FDA Device
Yes

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05969782 on ClinicalTrials.gov